MHMartin Huemer

Martin Huemer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Martin Huemer has a total of 75 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Safety and healthcare resource utilisation in patients undergoing left-atrial appendage closure - A nationwide analysis

    by T Thevathasan, S Degbeon, J Paul, L Fuereder, A L Gaul, J F Scheitz, G Stadler, A Rroku, S Lech, P Buspavanich, et al.

    Background: Percutaneous left-atrial appendage closure (LAAC) has emerged as a non-pharmacological alternative for stroke prevention in patients with atrial fibrillation (AF) not suitable for anticoagulation therapy. Real-world data on peri-procedural outcomes are limited. Purpose: To analyse outcomes of peri-procedural in-hospital safety and healthcare resource utilisation after percutaneous LAAC. Methods: The US National Inpatient Sample was utilised to identify AF patients undergoing LAAC from 2016 to 2019. Primary outcomes (safety) were in-hospital stroke or systemic embolism (SE), pericardial effusion (PE), major bleeding, device embolisation and mortality. Secondary outcomes (resource utilisation) were adverse discharge disposition, hospital length of stay (LOS) and treatment costs. Logistic and Poisson regression models were used to analye outcomes by adjusting for 10 confounders. Results: 11,240 adult patients (with 41.9% being female) with AF undergoing LAAC were included. SE decreased by 97% between 2016 and 2019 [95% Confidence Interval (CI) 0-0.24] (P=0.003), while a trend to lower numbers of other peri-procedural complications was determined. In-hospital mortality remained stable (0.14%). Hospital LOS decreased by 18% (0.78-0.87, P<0.001) and adverse discharge rate by 41% (95% CI 0.41-0.86, P=0.005) between 2016 and 2019, while hospital costs did not significantly change (P=0.2). Of note, female patients had a higher risk of PE (OR 2.86 [95% CI 2.41-6.39]) and SE (OR 5.0 [95% CI 1.28-43.6]), while patients with multiple comorbidities had higher risks of major bleeding (P<0.001), mortality (P=0.031), longer hospital LOS (P<0.001) and increased treatment costs (P=0.073). Male patients had the most peculiar decrease in adverse discharge rate between 2016 and 2019: OR 0.45 [95% CI 0.27-0.77]. Significant differences in all outcomes were observed between male and female patients across US regions (Figure). Subgroup analyses confirmed that female patients had a prolonged LOS and higher risk of adverse discharge disposition than male patients. Conclusions: LAAC has become a safer and more efficient procedure. Significant sex differences existed across US regions. Careful considerations should be taken when performing LAAC in female and comorbid patients.

  • P-wave detection performance of the BioMonitor III, Confirm Rx and Reveal Linq implantable loop recorders

    by Tobias Schreiber, Anja Cretnik, Patrick Schauerte, Philipp Lacour, Florian Blaschke, Sebastian Biewener, Saba Suhail, Verena Tscholl, Patrick Nagel, Ulf Landmesser, et al.


  • Open Access

    Safe procedures despite ultra low radiation doses during catheter ablations of atrial and ventricular arrhythmias—A multicenter experience

    by Philipp Attanasio, Martin Huemer, Nora Kaehler, Theresa Keller, Tobias Schreiber, Reinhard Niehues, Dimitra Katsani‐Potempa, Rolf Michael Klein, Ulf Landmesser, Isabel Deisenhofer, et al.

    Introduction: Despite the development of non‐fluoroscopic catheter visualization options, fluoroscopy is still used in most ablation procedures. The aim of this multicenter study was to evaluate the safety and efficacy of a new ultra‐low dose radiation protocol for EP procedures in a large number of patients.Methods and results: A total of 3462 consecutive patients (male 1926 (55.6%), age 64.4 ± 14.0 years, BMI 26.65 ± 4.70) undergoing radiofrequency ablation (left atrial (n = 2316 [66.9%], right atrial (n = 675 [19.5%], or ventricular (n = 471 [13.6%]) in three German centers were included in the analysis. Procedures were performed using a new ultra‐low dose protocol operating at 8nGy for fluoroscopy and 36nGy for cine‐loops. Additionally a very low framerate (2‐3FPS) was used. Using the new protocol very low Air kerma‐area product (KAP) values were achieved for left atrial ablations (104.25 ± 84.22 μGym2), right atrial ablations (70.98 ± 94.79 μGym2) and ablations for ventricular tachycardias or PVCs (78.62 ± 66.59 μGym2). Acute procedural success was achieved in 3289/3388 (97.1%) while the rate of major complications was very low compared to previously published studies not using low dose settings (n = 20, 0.6%).Conclusion: The ultra‐low dose, low framerate protocol leads to very low radiation doses for all EP procedures while neither procedural time, fluoroscopy time nor success or complication rates were compromised. When compared to current real‐world Air KAP data the new ultra‐low dose fluoroscopy protocol reduces radiation exposure by more than 90%.


  • Open Access

    Implantable loop recorders in patients with unexplained syncope: Clinical predictors of pacemaker implantation

    by Martin Huemer, Ann-Kristin Becker, Alexander Wutzler, Philipp Attanasio, Abdul S. Parwani, Philipp Lacour, Leif-Hendrik Boldt, Burkert Pieske, Wilhelm Haverkamp, Florian Blaschke

    Background: Implantable loop recorders (ILR) are a valuable tool for the investigation of unexplained syncopal episodes. The aim of this retrospective single center study was to identify predictive factors for pacemaker implantation in patients with unexplained syncope who underwent ILR insertion. Methods: 106 patients were retrospectively analyzed (mean age 59.1 years; 47.2% male) with unexplained syncope and negative conventional testing who underwent ILR implantation. The primary study endpoint was detection of symptomatic or asymptomatic bradycardia requiring pacemaker implantation. Results: The average follow-up period after ILR implantation was 20 ± 15 months. Pacemaker implantation according to current guidelines was necessary in 22 patients (20.8%), mean duration until index bradycardia was 81 ± 88 (2–350) days. Ten patients (45.5%) received a pacemaker due to sinus arrest, 7 patients (31.8%) due to third-degree atrioventricular block, 2 patients (9.1%) due to second-degree atrioventricular block and 1 patient (4.5%) due to atrial fibrillation with a slow ventricular rate. Three factors remained significant in multivariate analysis: obesity, which defined by a body mass index above 30 kg/m² (OR: 7.39, p = 0.014), a right bundle branch block (OR: 9.40, p = 0.023) and chronic renal failure as defined by a glomerular filtration rate of less than 60 ml/min (OR: 6.42, p = 0.035). Conclusions: Bradycardia is a frequent finding in patients undergoing ILR implantation due to unexplained syncope. Obesity, right bundle branch block and chronic renal failure are independent clinical predictors of pacemaker implantation. Background: Implantable loop recorders (ILR) are a valuable tool for the investigation of unexplained syncopal episodes. The aim of this retrospective single center study was to identify predictive factors for pacemaker implantation in patients with unexplained syncope who underwent ILR insertion. Methods: 106 patients were retrospectively analyzed (mean age 59.1 years; 47.2% male) with unexplained syncope and negative conventional testing who underwent ILR implantation. The primary study endpoint was detection of symptomatic or asymptomatic bradycardia requiring pacemaker implantation. Results: The average follow-up period after ILR implantation was 20 ± 15 months. Pacemaker implantation according to current guidelines was necessary in 22 patients (20.8%), mean duration until index bradycardia was 81 ± 88 (2–350) days. Ten patients (45.5%) received a pacemaker due to sinus arrest, 7 patients (31.8%) due to third-degree atrioventricular block, 2 patients (9.1%) due to second-degree atrioventricular block and 1 patient (4.5%) due to atrial fibrillation with a slow ventricular rate. Three factors remained significant in multivariate analysis: obesity, which defined by a body mass index above 30 kg/m² (OR: 7.39, p = 0.014), a right bundle branch block (OR: 9.40, p = 0.023) and chronic renal failure as defined by a glomerular filtration rate of less than 60 ml/min (OR: 6.42, p = 0.035). Conclusions: Bradycardia is a frequent finding in patients undergoing ILR implantation due to unexplained syncope. Obesity, right bundle branch block and chronic renal failure are independent clinical predictors of pacemaker implantation.


  • The effect of an ultra‐low frame rate and antiscatter grid‐less radiation protocol for cardiac device implantations

    by Philipp Attanasio, Tobias Schreiber, Abdul Parwani, Philipp Lacour, Burkert Pieske, Wilhelm Haverkamp, Florian Blaschke, Martin Huemer

    Background and aims: Antiscatter grids improve image contrast by absorbing scattered x‐ray beams, although by removing the antiscatter grid patient dose can be reduced as more x‐ray beams reach the image receptor. Additionally, there is a trend toward ultra‐low frame rates for radiation dose reduction during various electrophysiology procedures. As for most cardiac device implantations (CIED) image quality demands are usually modest, the purpose of this study was to assess the safety and efficacy of an ultra‐low frame rate and scatter grid‐less radiation protocol.Methods/results: A total of 140 patients undergoing CIED implantation between 2014 and 2017 were included in the study. Seventy patients (50%) implanted after implementation of the antiscatter grid‐less and ultra‐low frame rate protocol were matched to controls before the dose‐reduction protocol was established. Forty patients (28.6%) had a one‐chamber pacemaker or one‐chamber implantable cardioverter defibrillator (ICD) implantation/revision, 60 (42.9%) had a two‐chamber pacemaker or two‐chamber ICD implantation/revision, and 40 (28.6%) patients had a cardiac resynchronization therapy device implantation/revision. Removing the antiscatter‐grid and lowering the frame rate led to a 73% reduction of the overall dose area product (1,206 ± 2,015 vs 324 ± 422 μGym, P < 0.001). Procedural duration (95 ± 51 minutes vs 82 ± 44 minutes, P = 0.053) and rate of complications were not significantly different between the two groups.Conclusion: The use of an ultra‐low frame rate and antiscatter grid‐less radiation protocol significantly reduced radiation dose for implantation of CIED and led to very low average patient doses, while procedural duration and complication rates did not increase.


  • Safety and efficacy of catheter-based left atrial appendage closure in patients with contraindications for long-term anticoagulation

    by Adrian Seidel, Abdul S. Parwani, Florian Krackhardt, Martin Huemer, Philipp Attanasio, Wilhelm Haverkamp, Burkert Pieske, Leif-Hendrik Boldt

    Article: Safety and efficacy of catheter-based left atrial appendage closure in patients with contraindications for long-term anticoagulation - Minerva Cardioangiologica 2017 December;65(6):545-52 - Minerva Medica - Journals


  • Open Access

    P1544The effect of an ultra-low framerate and antiscatter grid-less radiation protocol for device implantation

    by T. Schreiber, P. Attanasio, B. Pieske, F. Blaschke, Lh. Boldt, W. Haverkamp, M. Huemer

    Background: Fluoroscopy is the most common technique for visualization of lead placement during cardiac electronic device (CIED) implantation. Especially implantation of CRT devices requires high radiation doses. Simple changes in the x-ray system settings can lead to a significant reduction of the total radiation dose. The purpose of this study was to assess the safety and efficacy of an ultra-low frame rate and scatter grid-less radiation protocol of various CIED implantations.

  • Catheter ablation of atrial flutter: A survey focusing on post ablation oral anticoagulation management and ECG monitoring

    by Philipp Attanasio, Tabea Budde, Philipp Lacour, Abdul Shokor Parwani, Burkert Pieske, Florian Blaschke, Wilhelm Haverkamp, Leif‐Hendrik Boldt, Martin Huemer

    Background: A considerable amount of patients with typical atrial flutter develop atrial fibrillation after cavotricuspid isthmus (CTI) ablation. No uniform recommendations are available to guide anticoagulation regimes or electrocardiogram (ECG) monitoring strategies after this procedure.Methods: We conducted a web‐based survey in electrophysiology (EP) centers in Germany, Switzerland, and Austria. Responses were received from 47 centers. The survey was designed to investigate variations in management of the following: ablation strategy, oral anticoagulation (OAC) management, and ECG monitoring after successful CTI ablation.Results: More than 55% of the participating centers assume that at least every third patient will develop atrial fibrillation during follow‐up. Despite this assumption, most EP experts (81%) would still stop OAC after CTI ablation even in patients with higher CHADS2‐VA2SC‐score, or even perform CTI in asymptomatic patients with the purpose to stop OAC (52%). Most experts agree that ECG monitoring is necessary during follow‐up. A majority still rely on short‐term monitoring tools like resting ECGs (7%) or Holter ECGs (43%), while continuous monitoring by implantable loop recorders (10%) are rarely used for postablation OAC management.Conclusion: A majority of the centers stop OAC in patients with higher CHADS2‐VA2SC‐score after CTI ablation. There is evidence that this practice might not be safe and lead to an increased number of ischemic strokes during follow‐up. This reflects the need for prospective studies to allow for clear guidelines regarding these issues.


  • Does the extent of left atrial arrhythmogenic substrate depend on the electroanatomical mapping technique: impact of pulmonary vein mapping catheter vs. ablation catheter

    by Martin Huemer, Daniel Qaiyumi, Philipp Attanasio, Abdul Parwani, Burkert Pieske, Florian Blaschke, Leif-Hendrik Boldt, Wilhelm Haverkamp, Alexander Wutzler

    Aims In persistent atrial fibrillation (AF), left atrial low-voltage areas and complex fractionated atrial electrograms (CFAEs) have been thoroughly discussed as critical substrate points for AF perpetuation. Thus, in patients undergoing pulmonary vein isolation, these sites are often considered additional ablation targets. Currently, mapping techniques for these substrate indicators are still under discussion. The aim of this study was to evaluate the impact of different mapping catheters on the detection of low-voltage areas and CFAE. Methods and results Two bipolar voltage maps and two CFAE left atrial maps were obtained each in 30 patients undergoing catheter ablation of AF using the following two different catheters: A four-pole ablation catheter (MAP, mapping and ablation catheter) (electrode size: tip: 4 mm, band: 1 mm; inter-electrode spacing: 0.5–5–2 mm) and a 10-pole circular pulmonary vein mapping catheter (CMC) (electrode size: 1 mm; inter-electrode spacing: 7–7–7 mm). Successively, low-voltage and CFAE area sizes were then compared between the two catheters. Areas with a bipolar voltage of P < 0.001). This was also significantly different for a bipolar voltage of P < 0.001). Complex fractionated atrial electrogram area sizes were significantly larger when obtained with the CMC compared with the MAP group (14.6 ± 10.9 vs. 19.4 ± 9.4 cm², P = 0.011). Conclusion Low-voltage and CFAE area size varies significantly between different mapping catheters. Mapping electrode settings have to be taken into consideration for the assessment of electroanatomical substrate of AF.


  • Open Access

    Safety and efficacy of applying a low-dose radiation fluoroscopy protocol in device implantations

    by Philipp Attanasio, Melika Mirdamadi, Jean-Yves Wielandts, Burkert Pieske, Florian Blaschke, Leif-Hendrik Boldt, Pierre Jais, Wilhelm Haverkamp, Martin Huemer

    For cardiac implantable electronic device (CIED) implantations, visualization of lead placement is necessary and fluoroscopy remains by far the most commonly used technique. With simple changes in the X-ray system settings, total radiation dose can be reduced significantly. The purpose of this study was to assess the safety and efficacy of various CIED implantations performed after implementation of a new dose reduction protocol (DRP). We conducted a retrospective chart review of 584 patients undergoing CIED implantation or revision in our hospital. Of these patients, 280 (48%) underwent the implantation prior to and 304 (52%) after the DRP introduction. The DRP included various changes for optimized image processing and exposure system settings to enable dose reduction, as well as a reduced frame rates (4 FPS for fluoroscopy and 7.5 FPS for cinematographic images). Of the 584 patients, 53 (9.1%) had a one-chamber pacemaker, 232 (39.7%) a two-chamber pacemaker, 133 (22.8%) a one-chamber ICD, 35 (6.0%) a two-chamber ICD, 82 (14.0%) a CRT ( de novo ) implantation, and 49 (8.3%) had an upgrade to a CRT device. DRP was associated with a 64% reduction of the dose-area product (1372 ± 2659 vs. 3792 ± 5025 cGcm 2 , P < 0.001), while fluoroscopy duration (13 ± 15 vs. 13 ± 15 min) and procedural duration (93 ± 52 vs. 92 ± 52 min.) did not significantly increase. Complication rates did not differ significantly between the two groups. The DRP proved to effectively reduce radiation dose for all types of CIED implantations. Fluoroscopy time, total procedure time, and the number of complications did not increase after introducing the DRP.